The retinoblastoma protein/p16INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma

Histopathology

Volumn 58, Issue 3, 2011, Pages 433-439

  Stankiewicz, Elzbieta ^a   Prowse, David M ^a   Ktori, Elena ^a   Cuzick, Jack ^a   Ambroisine, Laurence ^a   Zhang, Xiaoxi ^a   Kudahetti, Sakunthala ^a   Watkin, Nicholas ^b   Corbishley, Catherine ^b   Berney, Daniel M ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Human papillomavirus; P16INK4A; P21; P53; Penile squamous cell carcinoma; Retinoblastoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; VIRUS DNA;

ALPHAPAPILLOMAVIRUS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOHISTOCHEMISTRY; NONHUMAN; PAPILLOMAVIRUS INFECTION; PENIS CARCINOMA; PENIS SQUAMOUS CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; HUMANS; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; RETINOBLASTOMA PROTEIN; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN PAPILLOMAVIRUS;

EID: 79952094570     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03762.x     Document Type: Article

References (40)

1. Narayana AS, Olney LE, Loening SA, Weimar GW, Culp DA. Carcinoma of the penis: analysis of 219 cases. Cancer 1982; 49; 2185-2191.
2. Robinson D, Coupland V, Moller H. An analysis of temporal and generational trends in the incidence of anal and other HPV-related cancers in Southeast England. Br. J. Cancer 2009; 100; 527-531.
3. Bleeker MC, Heideman DA, Snijders PJ, Horenblas S, Dillner J, Meijer CJ. Penile cancer: epidemiology, pathogenesis and prevention. World J. Urol. 2009; 27; 141-150.
4. Cubilla LC, Velazquez EF, Barreto JE, Ayala G. The penis. In Mills SE, Carter D, Greenson JK, Oberman HA, Reuter VE, Stoler MH eds. Sternberg's diagnostic surgical pathology. Philadelphia: Lippincott Williams & Wilkins, 2004; 2233-2276.
5. Daling JR, Madeleine MM, Johnson LG et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int. J. Cancer 2005; 116; 606-616.
6. Munoz N. Human papillomavirus and cancer: the epidemiological evidence. J. Clin. Virol. 2000; 19; 1-5.
7. Pascual A, Pariente M, Godinez JM et al. High prevalence of human papillomavirus 16 in penile carcinoma. Histol. Histopathol. 2007; 22; 177-183.
8. Lont AP, Kroon BK, Horenblas S et al. Presence of high-risk human papillomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int. J. Cancer 2006; 119; 1078-1081.
9. IARC Working Group on the Evaluation of Carcinogenic Risks to Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 2007; 90; 1-636.
10. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int. J. Cancer 2009; 124; 1626-1636.
11. Rubin MA, Kleter B, Zhou M et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am. J. Pathol. 2001; 159; 1211-1218.
12. Trimble CL, Hildesheim A, Brinton LA, Shah KV, Kurman RJ. Heterogeneous etiology of squamous carcinoma of the vulva. Obstet. Gynecol. 1996; 87; 59-64.
13. Nevins JR. The Rb/E2F pathway and cancer. Hum. Mol. Genet. 2001; 10; 699-703.
14. Funk JO, Galloway DA. Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem. Sci. 1998; 23; 337-341.
15. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am. J. Pathol. 1998; 153; 1741-1748.
16. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137; 413-431.
17. Koyamatsu Y, Yokoyama M, Nakao Y et al. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas. Gynecol. Oncol. 2003; 90; 547-551.
18. Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 1997; 11; 2090-2100.
19. Prowse DM, Ktori EN, Chandrasekaran D, Prapa A, Baithun S. Human papillomavirus-associated increase in p16INK4A expression in penile lichen sclerosus and squamous cell carcinoma. Br. J. Dermatol. 2008; 158; 261-265.
20. Ferreux E, Lont AP, Horenblas S et al. Evidence for at least three alternative mechanisms targeting the p16INK4A/cyclin D/Rb pathway in penile carcinoma, one of which is mediated by high-risk human papillomavirus. J. Pathol. 2003; 201; 109-118.
21. Lam KY, Chan KW. Molecular pathology and clinicopathologic features of penile tumors: with special reference to analyses of p21 and p53 expression and unusual histologic features. Arch. Pathol. Lab. Med. 1999; 123; 895-904.
22. Sobin LH, Wittekind C. TNM classification of malignant tumours, 6th edn. New York: Wiley-Liss, 2002.
23. Martins AC, Faria SM, Cologna AJ, Suaid HJ, Tucci S Jr. Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J. Urol. 2002; 167; 89-92; discussion 92-83.
24. Guerrero D, Guarch R, Ojer A et al. Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU Int. 2008; 102; 747-755.
25. Yanagawa N, Osakabe M, Hayashi M, Tamura G, Motoyama T. Frequent epigenetic silencing of the FHIT gene in penile squamous cell carcinomas. Virchows Arch. 2008; 452; 377-382.
26. Shoji T, Tanaka F, Takata T et al. Clinical significance of p21 expression in non-small-cell lung cancer. J. Clin. Oncol. 2002; 20; 3865-3871.
27. Backes DM, Kurman RJ, Pimenta JM, Smith JS. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009; 20; 449-457.
28. Gregoire L, Cubilla AL, Reuter VE, Haas GP, Lancaster WD. Preferential association of human papillomavirus with high-grade histologic variants of penile-invasive squamous cell carcinoma. J. Natl Cancer Inst. 1995; 87; 1705-1709.
29. Stankiewicz E, Kudahetti SC, Prowse DM et al. HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod. Pathol. 2009; 22; 1160-1168.
30. Bezerra AL, Lopes A, Santiago GH, Ribeiro KC, Latorre MR, Villa LL. Human papillomavirus as a prognostic factor in carcinoma of the penis: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. Cancer 2001; 91; 2315-2321.
31. Senba M, Kumatori A, Fujita S et al. The prevalence of human papillomavirus genotypes in penile cancers from northern Thailand. J. Med. Virol. 2006; 78; 1341-1346.
32. Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J. Med. Virol. 2001; 64; 550-559.
33. Gargiulo F, De Francesco MA, Schreiber C et al. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res. 2007; 125; 176-182.
34. Nam EJ, Kim JW, Kim SW et al. The expressions of the Rb pathway in cervical intraepithelial neoplasia; predictive and prognostic significance. Gynecol. Oncol. 2007; 104; 207-211.
35. Lu DW, El-Mofty SK, Wang HL. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA. Mod. Pathol. 2003; 16; 692-699.
36. Hafkamp HC, Mooren JJ, Claessen SM et al. P21 Cip1/WAF1 expression is strongly associated with HPV-positive tonsillar carcinoma and a favorable prognosis. Mod. Pathol. 2009; 22; 686-698.
37. Lopes A, Bezerra AL, Pinto CA, Serrano SV, de Mell OC, Villa LL. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J. Urol. 2002; 168; 81-86.
38. Lam KY, Chan AC, Chan KW, Leung ML, Srivastava G. Expression of p53 and its relationship with human papillomavirus in penile carcinomas. Eur. J. Surg. Oncol. 1995; 21; 613-616.
39. Eichten A, Westfall M, Pietenpol JA, Munger K. Stabilization and functional impairment of the tumor suppressor p53 by the human papillomavirus type 16 E7 oncoprotein. Virology 2002; 295; 74-85.
40. Gartel AL. Is p21 an oncogene? Mol. Cancer Ther. 2006; 5; 1385-1386.